The role of asymmetric dimethylarginine (ADMA) and leptin in hypertensive patients
dc.contributor.author | Atamer, A. | |
dc.contributor.author | Ilan, N. | |
dc.contributor.author | Kocyigit, Y. | |
dc.contributor.author | Toprak, G. | |
dc.contributor.author | Ozbay, M. | |
dc.contributor.author | Celik, Y. | |
dc.date.accessioned | 2024-04-24T16:18:59Z | |
dc.date.available | 2024-04-24T16:18:59Z | |
dc.date.issued | 2007 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description | 76th Congress of the European-Atherosclerosis-Society -- JUN 10-13, 2007 -- Helsinki, FINLAND | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.description.sponsorship | European Atherosclerosis Soc | en_US |
dc.identifier.doi | 10.1016/S1567-5688(07)71407-1 | |
dc.identifier.endpage | 115 | en_US |
dc.identifier.issn | 1567-5688 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.startpage | 115 | en_US |
dc.identifier.uri | https://doi.org/10.1016/S1567-5688(07)71407-1 | |
dc.identifier.uri | https://hdl.handle.net/11468/16358 | |
dc.identifier.volume | 8 | en_US |
dc.identifier.wos | WOS:000247869100459 | |
dc.identifier.wosquality | Q1 | |
dc.indekslendigikaynak | Web of Science | |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Ireland Ltd | en_US |
dc.relation.ispartof | Atherosclerosis Supplements | |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Hypertension | en_US |
dc.subject | Leptin | en_US |
dc.subject | Adma | en_US |
dc.subject | Insulin Resistance | en_US |
dc.subject | Mda | en_US |
dc.subject | Lipoproteins | en_US |
dc.title | The role of asymmetric dimethylarginine (ADMA) and leptin in hypertensive patients | en_US |
dc.title | The role of asymmetric dimethylarginine (ADMA) and leptin in hypertensive patients | |
dc.type | Conference Object | en_US |